SCHEMBL18154686

SCHEMBL18154686

Nc1ccnc(Sc2ccc(S(=O)(=O)Cc3cccc(C(F)(F)F)c3)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.43
▸ GRM4 Q14833 1/20 0.41
▸ CA2 P00918 2/20 0.39
▸ ROCK1 Q13464 2/20 0.38
▸ NR3C2 P08235 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ KMT2A Q03164 1/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ MPO P05164 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ LTA4H P09960 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ SLC40A1 Q9NP59 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ CXCR5 P32302 1/20 0.35
▸ APLNR P35414 1/20 0.35
▸ CCR6 P51684 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353170 1.00 AKR1B1 (0.43) AKR1B1GRM4CA2ROCK1NR3C2
SCHEMBL18154809 0.84 ALDH1A1 (0.39) GRM4NR3C2POLB
SCHEMBL30353158 0.84 ALDH1A1 (0.39) GRM4NR3C2POLB
SCHEMBL18154717 0.79 PIK3C3 (0.42) CA2KMT2A
SCHEMBL30353164 0.79 PIK3C3 (0.42) CA2KMT2A
SCHEMBL18154833 0.79 PIK3C3 (0.44) AKR1B1GRM4NR3C2KMT2AMPO
SCHEMBL18154795 0.79 NAMPT (0.38) POLBKMT2AROCK2
SCHEMBL18154704 0.74 ALDH1A1 (0.34) —
SCHEMBL18154848 0.74 MEN1 (0.44) CA2POLBKMT2ACA1CA9
SCHEMBL20752339 0.74 POLB (0.59) AKR1B1CA2POLBKMT2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283482-A1 PLK4 INHIBITORS Ludwig Institute for Cancer Research Ltd (CH) 2018-02-21 — — EP disclosed
WO-2016166604-A1 PLK4 INHIBITORS LUDWIG INSTITUTE FOR CANCER RESEARCH LTD (CH) 2016-10-20 — — WO disclosed
Send feedback